A Multifunctional Nano-Delivery System Against Rheumatoid Arthritis by Combined Phototherapy, Hypoxia-Activated Chemotherapy, and RNA Interference
Xiangyu Li,Shixin Zhang,Miaomiao Zhang,Ge Li,Bo Yang,Xinyue Lu,Lesheng Teng,Youxin Li,Fengying Sun
DOI: https://doi.org/10.2147/IJN.S382252
IF: 7.033
2022-12-10
International Journal of Nanomedicine
Abstract:Xiangyu Li, &ast Shixin Zhang, &ast Miaomiao Zhang, Ge Li, Bo Yang, Xinyue Lu, Lesheng Teng, Youxin Li, Fengying Sun School of Life Sciences, Jilin University, Changchun, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fengying Sun, School of Life Sciences, Jilin University, 2699 Qianjin Street, Changchun, Jilin, 130012, People's Republic of China, Tel/Fax +86-431-85155320, Email Purpose: Effective therapy for rheumatoid arthritis (RA) keeps a challenge due to the complex pathogenesis of RA. It is not enough to completely inhibit the process of RA with any single therapy method. The purpose of the research is to compensate for the insufficiency of monotherapy using multiple treatment regimens with different mechanisms. Material and Methods: In this study, we developed a new method to synthesize mesoporous silica nanoparticles hybridized with photosensitizer PCPDTBT (HNs). Branched polyethyleneimine-folic acid (PEI-FA) could be coated on the surface of HNs through electrostatic interactions. It simultaneously blocked the hypoxia-activated prodrug tirapazamine loaded into the mesopores and binded with Mcl-1 siRNA (siMcl-1) that interfered with the expression of the anti-apoptotic protein Mcl-1. Released from the co-delivery nanoparticles (PFHNs/TM) Tirapazamine and siMcl-1 upon exposure to acidic conditions of endosomes/lysosomes in activated macrophages. Under NIR irradiation, photothermal therapy and photodynamic therapy derived from PCPDTBT, hypoxia-activated chemotherapy derived from tirapazamine, and RNAi derived from siMcl-1 were used for the combined treatment for RA by killing activated macrophages. PEI-FA-coated PFHNs/TM exhibited activated macrophage-targeting characteristics, thereby enhancing the in vitro and in vivo NIR-induced combined treatment of RA. Results: The prepared PFHNs/TM have high blood compatibility (far below 5% of hemolysis) and ideal in vitro phototherapy effect while controlling the TPZ release and binding siMcl-1. We prove that PEI-FA-coated PFHNs/TM not only protect the bound siRNA but also are selectively uptaked by activated macrophages through FA receptor-ligand-mediated endocytosis, and effectively silence the target anti-apoptotic protein by siMcl-1 transfection. In vivo, PFHNs/TM have also been revealed to be selectively enriched at the inflammatory site of RA, exhibiting NIR-induced anti-RA efficacy. Conclusion: Overall, these FA-functionalized, pH-responsive PFHNs/TM represent a promising platform for the co-delivery of chemical drugs and nucleic acids for the treatment of RA cooperating with NIR-induced phototherapy. Graphical Keywords: rheumatoid arthritis, nano-delivery system, phototherapy, hypoxia-activated chemotherapy, RNA interference Graphical Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that mainly affects the joints. 1 Activated macrophages are deeply involved in the systemic and joint pathologies of RA, including cartilage erosion and bone destruction, by secreting a large number of pro-inflammatory factors and chemokines, which makes them an ideal target for the treatment of RA. 2–4 In addition, a large number of folate receptor-β (FR-β) exists on the surface of activated macrophages. The overexpression of FR-β on the cell surface provides convenience for the targeted delivery of folic acid (FA) functionalized nanocarriers to activated macrophages. 5,6 The resistance of activated macrophages to apoptosis is one of the reasonable explanations for the difficulty of a complete cure for RA. And the targeted delivery of chemical drugs through nanotechnology may be an effective way to kill activated macrophages for the treatment of RA. Near-infrared (NIR) induced phototherapy is an effective, non-invasive and mild technique with excellent time-spatial specificity method to kill the target cells, including photodynamic therapy (PDT) and photothermal therapy (PTT). 7–11 Among them, PTT employs a photothermal agent to convert the photon energy from NIR laser into heat energy, causing local overheating to thermally ablate target cells while causing minimal damage to the surrounding normal cells and tissues. 12–14 Unlike PTT, NIR irradiation induces photosensitizers to convert nearby molecular O 2 into cytotoxic ROS (such as singlet oxygen) to destroy target cells, which is defined as PDT. 15 As an emerging material for NIR-induced phototherapy, the semiconducting polymer PCPDTBT with the characteristics of both a photothermal agent and a photosensitizer has been extensively investigated. 16,17 It is obvious that the efficacy of PDT depends on the supply -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology